Filing Overview
Registrant: Redwoods Acquisition Corp., not Greenland Mines Ltd. Form 8-K reporting a special stockholder meeting held April 12, 2024; the report was signed April 18, 2024.
Redwoods reported stockholder approval of its proposed business combination with ANEW MEDICAL, INC. Following closing, Redwoods is expected to change its name to ANEW MEDICAL, INC., with ANEW surviving as a wholly owned subsidiary.
Business Combination and Vote Results
As of the February 16, 2024 record date, 5,165,194 common shares were outstanding and entitled to vote. A total of 4,189,027 shares were represented at the meeting.
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Business combination and related transactions | 4,185,975 | 3,052 | 0 |
| Second amended and restated certificate of incorporation | 4,135,672 | 53,355 | 0 |
| Advisory governance provisions | 4,135,672 | 53,355 | 0 |
| ANEW 2023 Stock Incentive Plan | 4,135,672 | 53,355 | 0 |
| Issuance exceeding 20% of outstanding shares and resulting change in control | 4,185,875 | 3,152 | 0 |
All five director nominees were elected. Joseph Sinkule received 4,138,720 votes for and 50,307 withheld; each of Shalom Z. Hirschman, Samuel Zentman, Jon W. McGarity, and Edward Cong Wang received 4,189,023 votes for and 4 withheld.
Redemptions and Financial Metrics
Stockholders elected to redeem 1,739,776 shares of Redwoods Class A common stock in connection with the meeting.
- The filing does not provide revenue, net income, margins, operating cash flow, cash balances, debt, liquidity ratios, enterprise value, or post-transaction equity value.
- The filing does not provide a clear pro forma share count or the amount of cash remaining after redemptions.
Material Changes, Outlook, and Risks
The material development was approval of the proposed ANEW transaction, the amended charter, the equity incentive plan, the new directors, and the proposed issuance of more than 20% of the company’s outstanding stock. The filing text does not confirm that the transaction had closed as of the report date.
Forward-looking statements reference anticipated transaction benefits, integration plans, synergies, revenue opportunities, future financial and operating performance, and expected management and governance. These statements are not guarantees and are subject to transaction-closing conditions, redemption levels, ANEW business and strategy risks, the ability to realize anticipated benefits, general economic and industry conditions, and risks described in the Form S-4, proxy statement/prospectus, and other SEC filings.
The Item 7.01 redemption disclosure was furnished and is not deemed filed for purposes of Section 18 of the Exchange Act, except as otherwise specified.
Investor Verification Items
- Verify whether and when the ANEW business combination closed and whether the registrant completed its name change.
- Confirm the final post-redemption cash balance, capitalization, ownership percentages, and securities issued in the transaction.
- Review the Form S-4, proxy statement/prospectus, and subsequent SEC filings for transaction conditions, financing terms, dilution, and updated risk factors.
- Assess ANEW’s historical and projected revenue, profitability, cash flow, liquidity, debt, and operating metrics, which are not provided in this 8-K.
- Confirm the final composition and roles of the combined company’s board and management.